Pharmacokinetic Service Market Report: Trends, Forecast and Competitive Analysis
In Progress. Get it in 2 to 4 weeks by ordering today
The future of the pharmacokinetic service market looks promising with opportunities in the hospitals and pharmaceutical companies. The global pharmacokinetic service market is expected to grow with a CAGR of 7%-9% from 2020 to 2025. The major drivers for this market are to reduce concerns about high drug attrition and enable early identification of potential challenge.
A total of XX figures / charts and XX tables are provided in more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global pharmacokinetic service market report, please download the report brochure.
In this market, small molecules pharmacokinetic service is the largest drug type of pharmacokinetics service. Growth in various segments of the pharmacokinetic market are given below:
The study includes trends and forecast for the global pharmacokinetic service market by drug type, end user, and region as follows:
By Drug Type [Value ($ Million) shipment analysis for 2014 – 2025]:
Small Molecule Pharmacokinetic Services Large Molecule (Biopharmaceutical) Pharmacokinetic Services
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
HospitalsPharmaceutical Companies
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North AmericaUnited StatesCanada MexicoEuropeUnited KingdomSpainGermanyFranceAsia PacificChinaIndiaJapanThe Rest of the WorldBrazil
Some of the pharmacokinetic service companies profiled in this report include Evotec, Certara, Pacific BioLab, GVK Biosciences, Shanghai Medicilon, Pharmaceutical Product Development, Charles River Laboratories International, PAREXEL International Corporation, Eurofins Scientific, and Frontage Labs.
Lucintel forecasts that small molecule pharmacokinetic services will remain the largest drug type segment over the forecast period due to increasing emphasize on studying molecule of smaller atomic weight and drug metabolism.
North America will remain the largest region, and it is also expected to witness the highest growth over the forecast period due to the presence of a large number prominent pharmaceutical companies in the region and presence of effective regulatory structure pertaining to drug development processes including PKPD (pharmacokinetic and pharmacodynamic determinant) and toxicology studies in the region.
Features of the Global Pharmacokinetic Service Market
Market Size Estimates: Global pharmacokinetic service market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global pharmacokinetic service market size by various segments, such as drug type and end user in terms of value.Regional Analysis: Global pharmacokinetic service market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different drug type, end user, and region for the global pharmacokinetic service market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global pharmacokinetic service market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global pharmacokinetic service market by drug type (small molecule pharmacokinetic services and large molecule (biopharmaceutical) pharmacokinetic), end user (hospitals and pharmaceutical companies), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global pharmacokinetic service market?
Q.5 What are the business risks and threats to the global pharmacokinetic service market?
Q.6 What are the emerging trends in this pharmacokinetic service market and the reasons behind them?
Q.7 What are some changing demands of customers in this pharmacokinetic service market?
Q.8 What are the new developments in this pharmacokinetic service market? Which companies are leading these developments?
Q.9 Who are the major players in this pharmacokinetic service market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this pharmacokinetic service market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global pharmacokinetic service market?
The future of the pharmacokinetic service market looks promising with opportunities in the hospitals and pharmaceutical companies. The global pharmacokinetic service market is expected to grow with a CAGR of 7%-9% from 2020 to 2025. The major drivers for this market are to reduce concerns about high drug attrition and enable early identification of potential challenge.
A total of XX figures / charts and XX tables are provided in more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global pharmacokinetic service market report, please download the report brochure.
In this market, small molecules pharmacokinetic service is the largest drug type of pharmacokinetics service. Growth in various segments of the pharmacokinetic market are given below:
The study includes trends and forecast for the global pharmacokinetic service market by drug type, end user, and region as follows:
By Drug Type [Value ($ Million) shipment analysis for 2014 – 2025]:
Small Molecule Pharmacokinetic Services Large Molecule (Biopharmaceutical) Pharmacokinetic Services
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
HospitalsPharmaceutical Companies
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North AmericaUnited StatesCanada MexicoEuropeUnited KingdomSpainGermanyFranceAsia PacificChinaIndiaJapanThe Rest of the WorldBrazil
Some of the pharmacokinetic service companies profiled in this report include Evotec, Certara, Pacific BioLab, GVK Biosciences, Shanghai Medicilon, Pharmaceutical Product Development, Charles River Laboratories International, PAREXEL International Corporation, Eurofins Scientific, and Frontage Labs.
Lucintel forecasts that small molecule pharmacokinetic services will remain the largest drug type segment over the forecast period due to increasing emphasize on studying molecule of smaller atomic weight and drug metabolism.
North America will remain the largest region, and it is also expected to witness the highest growth over the forecast period due to the presence of a large number prominent pharmaceutical companies in the region and presence of effective regulatory structure pertaining to drug development processes including PKPD (pharmacokinetic and pharmacodynamic determinant) and toxicology studies in the region.
Features of the Global Pharmacokinetic Service Market
Market Size Estimates: Global pharmacokinetic service market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global pharmacokinetic service market size by various segments, such as drug type and end user in terms of value.Regional Analysis: Global pharmacokinetic service market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different drug type, end user, and region for the global pharmacokinetic service market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global pharmacokinetic service market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global pharmacokinetic service market by drug type (small molecule pharmacokinetic services and large molecule (biopharmaceutical) pharmacokinetic), end user (hospitals and pharmaceutical companies), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global pharmacokinetic service market?
Q.5 What are the business risks and threats to the global pharmacokinetic service market?
Q.6 What are the emerging trends in this pharmacokinetic service market and the reasons behind them?
Q.7 What are some changing demands of customers in this pharmacokinetic service market?
Q.8 What are the new developments in this pharmacokinetic service market? Which companies are leading these developments?
Q.9 Who are the major players in this pharmacokinetic service market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this pharmacokinetic service market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global pharmacokinetic service market?
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Pharmacokinetic Service Market Trends and Forecast
3.3: Global Pharmacokinetic Service Market by Drug Type
3.3.1: Small Molecule Pharmacokinetic Services
3.3.2: Large Molecule (Biopharmaceutical) Pharmacokinetic Services
3.4: Global Pharmacokinetic Service Market by End User
3.4.1: Hospitals
3.4.2: Pharmaceutical Companies
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Pharmacokinetic Service Market by Region
4.2: North American Pharmacokinetic Service Market
4.2.1: Market by Drug Type: Small Molecule Pharmacokinetic Services and Large Molecule (Biopharmaceutical) Pharmacokinetic Services
4.2.2: Market by End User: Hospitals and Pharmaceutical Companies
4.2.3: The United States Pharmacokinetic Service Market
4.2.4: The Canadian Pharmacokinetic Service Market
4.2.5: The Mexican Pharmacokinetic Service Market
4.3: European Pharmacokinetic Service Market
4.3.1: Market by Drug Type: Small Molecule Pharmacokinetic Services and Large Molecule (Biopharmaceutical) Pharmacokinetic Services
4.3.2: Market by End User: Hospitals and Pharmaceutical Companies
4.3.3: The United Kingdom Pharmacokinetic Service Market
4.3.4: The Spanish Pharmacokinetic Service Market
4.3.5: The German Pharmacokinetic Service Market
4.3.6: The French Pharmacokinetic Service Market
4.4: APAC Pharmacokinetic Service Market
4.4.1: Market by Drug Type: Small Molecule Pharmacokinetic Services and Large Molecule (Biopharmaceutical) Pharmacokinetic Services
4.4.2: Market by End User: Hospitals and Pharmaceutical Companies
4.4.3: The Chinese Pharmacokinetic Service Market
4.4.4: The Indian Pharmacokinetic Service Market
4.4.5: The Japanese Pharmacokinetic Service Market
4.5: ROW Pharmacokinetic Service Market
4.5.1: Market by Drug Type: Small Molecule Pharmacokinetic Services and Large Molecule (Biopharmaceutical) Pharmacokinetic Services
4.5.2: Market by End User: Hospitals and Pharmaceutical Companies
4.5.3: Brazilian Pharmacokinetic Service Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Pharmacokinetic Service Market by Drug Type
7.1.2: Growth Opportunities for the Global Pharmacokinetic Service Market by End User
7.1.4: Growth Opportunities for the Global Pharmacokinetic Service Market by Region
7.2: Emerging Trends in the Global Pharmacokinetic Service Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Pharmacokinetic Service Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Pharmacokinetic Service Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Evotec
8.2: Certara
8.3: Pacific BioLab
8.4: GVK Biosciences
8.5: Shanghai Medicilon
8.6: Pharmaceutical Product Development
8.7: Charles River Laboratories International
8.8: PAREXEL International Corporation
8.9: Eurofins Scientific
8.10: Frontage Labs
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Pharmacokinetic Service Market Trends and Forecast
3.3: Global Pharmacokinetic Service Market by Drug Type
3.3.1: Small Molecule Pharmacokinetic Services
3.3.2: Large Molecule (Biopharmaceutical) Pharmacokinetic Services
3.4: Global Pharmacokinetic Service Market by End User
3.4.1: Hospitals
3.4.2: Pharmaceutical Companies
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Pharmacokinetic Service Market by Region
4.2: North American Pharmacokinetic Service Market
4.2.1: Market by Drug Type: Small Molecule Pharmacokinetic Services and Large Molecule (Biopharmaceutical) Pharmacokinetic Services
4.2.2: Market by End User: Hospitals and Pharmaceutical Companies
4.2.3: The United States Pharmacokinetic Service Market
4.2.4: The Canadian Pharmacokinetic Service Market
4.2.5: The Mexican Pharmacokinetic Service Market
4.3: European Pharmacokinetic Service Market
4.3.1: Market by Drug Type: Small Molecule Pharmacokinetic Services and Large Molecule (Biopharmaceutical) Pharmacokinetic Services
4.3.2: Market by End User: Hospitals and Pharmaceutical Companies
4.3.3: The United Kingdom Pharmacokinetic Service Market
4.3.4: The Spanish Pharmacokinetic Service Market
4.3.5: The German Pharmacokinetic Service Market
4.3.6: The French Pharmacokinetic Service Market
4.4: APAC Pharmacokinetic Service Market
4.4.1: Market by Drug Type: Small Molecule Pharmacokinetic Services and Large Molecule (Biopharmaceutical) Pharmacokinetic Services
4.4.2: Market by End User: Hospitals and Pharmaceutical Companies
4.4.3: The Chinese Pharmacokinetic Service Market
4.4.4: The Indian Pharmacokinetic Service Market
4.4.5: The Japanese Pharmacokinetic Service Market
4.5: ROW Pharmacokinetic Service Market
4.5.1: Market by Drug Type: Small Molecule Pharmacokinetic Services and Large Molecule (Biopharmaceutical) Pharmacokinetic Services
4.5.2: Market by End User: Hospitals and Pharmaceutical Companies
4.5.3: Brazilian Pharmacokinetic Service Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Pharmacokinetic Service Market by Drug Type
7.1.2: Growth Opportunities for the Global Pharmacokinetic Service Market by End User
7.1.4: Growth Opportunities for the Global Pharmacokinetic Service Market by Region
7.2: Emerging Trends in the Global Pharmacokinetic Service Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Pharmacokinetic Service Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Pharmacokinetic Service Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Evotec
8.2: Certara
8.3: Pacific BioLab
8.4: GVK Biosciences
8.5: Shanghai Medicilon
8.6: Pharmaceutical Product Development
8.7: Charles River Laboratories International
8.8: PAREXEL International Corporation
8.9: Eurofins Scientific
8.10: Frontage Labs
